Great work from the Oncosil team in Q4, however sales in Q4 a bit behind expectations given recent break even remarks at Webinar.
What then is responsible for recent 100% SP appreciation and continued strength? - certainly not a pump.
Besides recent board addition with PH and capital injection by Pengana, I believe there is something else in the bush.
A bid perhaps?
Do your own research or ask your financial advisor.
Ann: Quarterly Activities/Appendix 4C Cash Flow Report, page-2
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.16 |
Change
-0.010(0.86%) |
Mkt cap ! $21.74M | |||
| Open | High | Low | Value | Volume |
| $1.17 | $1.17 | $1.14 | $80.47K | 69.48K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 2150 | $1.16 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.17 | 7380 | 1 |
View Market Depth
| Last trade - 16.10pm 25/07/2025 (20 minute delay) ? |
| OSL (ASX) Chart |